<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35091688</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1476-5365</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>57</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Bone marrow transplantation</Title>
          <ISOAbbreviation>Bone Marrow Transplant</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy.</ArticleTitle>
        <Pagination>
          <StartPage>661</StartPage>
          <EndPage>663</EndPage>
          <MedlinePgn>661-663</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41409-022-01562-4</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Feng</LastName>
            <ForeName>Jingjing</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-1607-4499</Identifier>
            <AffiliationInfo>
              <Affiliation>Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Hematology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shao</LastName>
            <ForeName>Mi</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Hematology, Zhejiang University, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>Yongxian</ForeName>
            <Initials>Y</Initials>
            <Identifier Source="ORCID">0000-0001-9564-1852</Identifier>
            <AffiliationInfo>
              <Affiliation>Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. 1313016@zju.edu.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, China. 1313016@zju.edu.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Hematology, Zhejiang University, Hangzhou, China. 1313016@zju.edu.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China. 1313016@zju.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>He</ForeName>
            <Initials>H</Initials>
            <Identifier Source="ORCID">0000-0002-2723-1621</Identifier>
            <AffiliationInfo>
              <Affiliation>Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. huanghe@zju.edu.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou, China. huanghe@zju.edu.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Hematology, Zhejiang University, Hangzhou, China. huanghe@zju.edu.cn.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China. huanghe@zju.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Bone Marrow Transplant</MedlineTA>
        <NlmUniqueID>8702459</NlmUniqueID>
        <ISSNLinking>0268-3369</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011948">Receptors, Antigen, T-Cell</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000076962">Receptors, Chimeric Antigen</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D064987" MajorTopicYN="N">Cell- and Tissue-Based Therapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016219" MajorTopicYN="N">Immunotherapy, Adoptive</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011948" MajorTopicYN="N">Receptors, Antigen, T-Cell</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000076962" MajorTopicYN="Y">Receptors, Chimeric Antigen</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>29</Day>
          <Hour>5</Hour>
          <Minute>44</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35091688</ArticleId>
        <ArticleId IdType="pmc">PMC8795291</ArticleId>
        <ArticleId IdType="doi">10.1038/s41409-022-01562-4</ArticleId>
        <ArticleId IdType="pii">10.1038/s41409-022-01562-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, et al.  Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. N Engl J Med. 2018;380:45–56. doi: 10.1056/NEJMoa1804980.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1804980</ArticleId>
            <ArticleId IdType="pubmed">30501490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maude SL, Laetsch TW, Buechner J, Rives S, Boyer M, Bittencourt H, et al.  Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med. 2018;378:439–48.. doi: 10.1056/NEJMoa1709866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1709866</ArticleId>
            <ArticleId IdType="pmc">PMC5996391</ArticleId>
            <ArticleId IdType="pubmed">29385370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park JH, Rivière I, Gonen M, Wang X, Sénéchal B, Curran KJ, et al.  Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N Engl J Med. 2018;378:449–59.. doi: 10.1056/NEJMoa1709919.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1709919</ArticleId>
            <ArticleId IdType="pmc">PMC6637939</ArticleId>
            <ArticleId IdType="pubmed">29385376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gutgarts V, Jain T, Zheng J, Maloy MA, Ruiz JD, Pennisi M, et al. Acute kidney injury after CAR-T cell therapy: low incidence and rapid recovery. Biol Blood Marrow Transplant. 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Burstein DS, Maude S, Grupp S, Griffis H, Rossano J, Lin K. Cardiac profile of chimeric antigen receptor T cell therapy in children: a single-institution experience. Biol Blood Marrow Transpl. 2018;24:1590–5. doi: 10.1016/j.bbmt.2018.05.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbmt.2018.05.014</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee DW, Santomasso BD, Locke FL, Ghobadi A, Turtle CJ, Brudno JN, et al.  ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transpl. 2019;25:625–38.. doi: 10.1016/j.bbmt.2018.12.758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbmt.2018.12.758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Case R, Ramaniuk A, Martin P, Simpson PJ, Harden C, Ataya A. Systemic capillary leak syndrome secondary to coronavirus disease 2019. Chest. 2020;158:e267–e8.. doi: 10.1016/j.chest.2020.06.049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2020.06.049</ArticleId>
            <ArticleId IdType="pmc">PMC7332444</ArticleId>
            <ArticleId IdType="pubmed">32622823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de Chambrun MP, Cohen-Aubart F, Donker DW, Cariou P-L, Luyt C-E, Combes A, et al. SARS-CoV-2-induces acute and refractory relapse of systemic capillary leak syndrome (Clarkson’s disease). Am J Med. 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>de Chambrun MP, Constantin J-M, Mathian A, Quemeneur C, Lepere V, Combes A, et al.  Clarkson’s disease episode or secondary systemic capillary leak-syndrome: that is the question! Chest. 2021;159:441. doi: 10.1016/j.chest.2020.07.084.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2020.07.084</ArticleId>
            <ArticleId IdType="pmc">PMC7831696</ArticleId>
            <ArticleId IdType="pubmed">33422212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu MA, Fossali T, Pandolfi L, Carsana L, Ottolina D, Frangipane V, et al. COVID-19: The key role of pulmonary capillary leakage. An observational cohort study. medRxiv. 2020. https://www.medrxiv.org/content/10.1101/2020.05.17.20104877v1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/2020.05.17.20104877v1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casadei Gardini A, Aquilina M, Oboldi D, Lucchesi A, Carloni S, Tenti E, et al.  Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease. BMC Cancer. 2013;13:542. doi: 10.1186/1471-2407-13-542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2407-13-542</ArticleId>
            <ArticleId IdType="pmc">PMC3840643</ArticleId>
            <ArticleId IdType="pubmed">24215543</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strati P, Ahmed S, Furqan F, Fayad LE, Lee HJ, Iyer SP, et al.  Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma. Blood. 2021;137:3272–6. doi: 10.1182/blood.2020008865.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood.2020008865</ArticleId>
            <ArticleId IdType="pmc">PMC8351896</ArticleId>
            <ArticleId IdType="pubmed">33534891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu S, Deng B, Pan J, Yin Z, Lin Y, Ling Z, et al.  Corticosteroids do not influence the efficacy and kinetics of CAR-T cells for B-cell acute lymphoblastic leukemia. Blood. 2019;134:228. doi: 10.1182/blood-2019-123051.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2019-123051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie Z, Chan EC, Long LM, Nelson C, Druey KM. High-dose intravenous immunoglobulin therapy for systemic capillary leak syndrome (Clarkson disease) Am J Med. 2015;128:91–5. doi: 10.1016/j.amjmed.2014.08.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjmed.2014.08.015</ArticleId>
            <ArticleId IdType="pmc">PMC4282822</ArticleId>
            <ArticleId IdType="pubmed">25193271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prete M, Urso L, Fatone MC, Pinto V, Perosa F. Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins: a case report. Medicine. 2016;95:e2648. doi: 10.1097/MD.0000000000002648.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000002648</ArticleId>
            <ArticleId IdType="pmc">PMC4748902</ArticleId>
            <ArticleId IdType="pubmed">26844485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Natterer J, Perez MH, Di Bernardo S. Capillary leak leading to shock in Kawasaki disease without myocardial dysfunction. Cardiol Young. 2012;22:349–52. doi: 10.1017/S1047951111001314.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S1047951111001314</ArticleId>
            <ArticleId IdType="pubmed">21933461</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
